In support of this, renoprotection43 is seen following blockade of diabetes-induced increases in renal reabsorption of glucose and sodium using SGLT2 inhibitors, which also decrease renal oxygen consumption44,45 and GFR41,46. Here, SLC5A2 is linked to diabetes mellitus.